Exploring Aztreonam in Combination with Ceftazidime-Avibactam or Meropenem-Vaborbactam as Potential Treatments for Metallo- and Serine-β-Lactamase-Producing Enterobacteriaceae [PDF]
Mark Biagi +5 more
openalex +1 more source
Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion. [PDF]
Trozzi I +4 more
europepmc +1 more source
Novel Antibiotics and Emerging Resistance: <i>In Vitro</i> Activity of Five Antimicrobials Against Intensive Care Unit Isolates from a Turkish Tertiary Care Hospital. [PDF]
Kutlu HH +3 more
europepmc +1 more source
Drug-Drug Interactions in Recently Approved Antibacterials: A Mini Review. [PDF]
Baccari I, Bergmann F, Zeitlinger M.
europepmc +1 more source
In vivo pharmacokinetic analysis of meropenem/vaborbactam during continuous venovenous haemodialysis
Wesley D Kufel +5 more
openaire +2 more sources
Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]
Frontiers Production Office.
europepmc +1 more source
Effectiveness and safety of meropenem-vaborbactam versus ceftazidime-avibactam in multidrug-resistant Gram-negative infections: a systematic review and meta-analysis with trial sequential analysis. [PDF]
Mohammad S +4 more
europepmc +1 more source
Meropenem/vaborbactam activity against carbapenem-resistant Klebsiella pneumoniae from catheter-related bloodstream infections [PDF]
Francesca Sivori +10 more
openalex +1 more source

